1. Idiopathic Inflammatory Myopathies: Current Trends in Pathogenesis, Clinical Features, and Up-to-Date Treatment Recommendations 
Floranne C. Ernste, MD, Ann M. Reed, MD 
Mayo Clinic Proceedings 
Volume 88, Issue 1, Pages (January 2013)
DOI: /j.mayocp
Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

2. Figure 1
Initial management of uncomplicated, newly diagnosed idiopathic inflammatory myopathy in adult patients. IBW = ideal body weight; MTX = methotrexate.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

3. Figure 2
Treatment of idiopathic inflammatory myopathy refractory to conventional therapy or with severe organ-threatening manifestations such as interstitial lung disease, severe dysphagia with weight loss, severe weakness, or cardiomyopathy. CYC = cyclophosphamide; CSA = cyclosporine A; IV = intravenous; IVIG = intravenous immunoglobulin; JDM = juvenile dermatomyositis.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions